WELLINGTON MANAGEMENT GROUP LLP - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,630,759
-45.0%
313,910
-28.2%
0.00%
-33.3%
Q2 2023$17,524,614
+13.4%
437,350
+15.5%
0.00%0.0%
Q1 2023$15,457,930
-39.6%
378,778
-42.9%
0.00%
-40.0%
Q4 2022$25,600,824
-49.7%
663,062
-30.7%
0.01%
-54.5%
Q3 2022$50,906,000
+17.5%
957,068
+28.8%
0.01%
+22.2%
Q2 2022$43,317,000
-16.1%
742,989
+9.9%
0.01%0.0%
Q1 2022$51,620,000
+1108.3%
676,365
+852.7%
0.01%
+800.0%
Q4 2021$4,272,000
-80.5%
70,995
-80.6%
0.00%
-75.0%
Q4 2020$21,906,000
-2.5%
366,071
-2.0%
0.00%
-20.0%
Q3 2020$22,464,000
+14.3%
373,654
-0.2%
0.01%
+25.0%
Q2 2020$19,650,000
+347.3%
374,510
+270.8%
0.00%
+300.0%
Q2 2019$4,393,000
+12.3%
101,000
-1.7%
0.00%0.0%
Q1 2019$3,912,000
+28.8%
102,773
+45.5%
0.00%0.0%
Q4 2018$3,038,000
+288.5%
70,633
+330.6%
0.00%
Q2 2017$782,000
+4.5%
16,4030.0%0.00%
Q1 2017$748,000
-9.9%
16,403
-36.2%
0.00%
Q4 2016$830,000
-63.2%
25,691
+10.3%
0.00%
-100.0%
Q3 2014$2,258,000
-95.6%
23,300
-95.8%
0.00%
-92.9%
Q2 2014$50,921,000
+47.2%
554,332
+12.1%
0.01%
+40.0%
Q1 2014$34,595,000
-32.7%
494,288
-44.7%
0.01%
-33.3%
Q4 2013$51,413,000
+18.1%
894,295
-1.2%
0.02%
+7.1%
Q3 2013$43,517,000
+381.4%
904,917
+190.3%
0.01%
+366.7%
Q2 2013$9,039,000311,7000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders